Source comparison
Comparison Table: CJC-1295 Variants and Key Research Characteristics
For researchers, selecting the right variant of CJC-1295 is crucial for achieving specific study objectives. Here's a quick comparison to help delineate the primary characteristics: Half-Life Extended (several days) Short (minutes) Mechanism GHRH analog, susta
This comparison does not assign a generated winner or score.
- For researchers, selecting the right variant of CJC-1295 is crucial for achieving specific study objectives. Here's a quick comparison to help delineate the primary characteristics:
- Half-Life
- Extended (several days)
- Short (minutes)
- Mechanism
- GHRH analog, sustained GH release
- GHRH analog, pulsatile GH release
- GHRP, direct GH secretagogue
- GH Secretion
- Broad, consistent elevation
- Acute, natural-like pulses
- Potent, selective, natural-like pulses
- Frequency
- Less frequent (e.g., 1-2x/week)
- More frequent (e.g., 1-3x/day)
- Primary Studies
- Long-term GH optimization, recovery
- Synergistic GH release with GHRPs
- Synergistic GH release with GHRHs
- Side Effects
- Generally mild, typical GH effects
- Generally mild, fewer hunger side effects
- We often find researchers combining the 'no DAC' version with a GHRP like Ipamorelin, creating a powerful synergy for modulating GH release. This approach (which we've refined over years) delivers real results in terms of controlled and measurable GH patterns. For example, the Tesamorelin + Ipamorelin Blend offers a different but equally effective avenue for research into synergistic GH release.